Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia

por Wen, Xiang-mei, Xu, Zi-jun, Jin, Ye, Xia, Pei-hui, Ma, Ji-chun, Qian, Wei, Lin, Jiang, Qian, Jun
Publicado 2021

Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia

por Xu, Zi‐jun, Jin, Ye, Zhang, Xin‐long, Xia, Pei‐hui, Wen, Xiang‐mei, Ma, Ji‐chun, Lin, Jiang, Qian, Jun
Publicado 2022

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia

por Wang, Shi-sen, Xu, Zi-jun, Jin, Ye, Ma, Ji-chun, Xia, Pei-hui, Wen, Xiangmei, Mao, Zhen-wei, Lin, Jiang, Qian, Jun
Publicado 2021

SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia

por Gu, Yu, Xu, Zi-jun, Zhou, Jing-dong, Wen, Xiang-mei, Jin, Ye, Yuan, Qian, Xia, Pei-hui, Feng, Yuan, Yang, Lei, Lin, Jiang, Qian, Jun
Publicado 2022

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia

por Xu, Zi-Jun, Wen, Xiang-Mei, Zhang, Yuan-Cui, Jin, Ye, Ma, Ji-Chun, Gu, Yu, Chen, Xin-Yi, Xia, Pei-Hui, Qian, Wei, Lin, Jiang, Qian, Jun
Publicado 2022

Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia

por Zhang, Ling‐yi, Jin, Ye, Xia, Pei‐hui, Lin, Jiang, Ma, Ji‐chun, Li, Ting, Liu, Zi‐qi, Xiang, He‐lin, Cheng, Chen, Xu, Zi‐jun, Zhou, Hong, Qian, Jun
Publicado 2021